In a deal valued at $430 million, Holland & Knight partners Rodney Bell and Danielle Price advised Sunovion Pharmaceuticals Inc. on its acquisition of Elevation Pharmaceuticals and the company's lead drug, EP-101.
Font Size: 
Dealmakers: Holland & Knight partners work $430 million pharmaceutical deal
Daily Business Review
October 10, 2012
This article requires premium access
This article requires premium access to Daily Business Review. Please sign in or subscribe to read the full text.
